Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia

Leukemia

Volumn 12, Issue 7, 1998, Pages 1056-1063

  Venditti, A ^a   Del Poeta, G ^a   Buccisano, F ^a   Tamburini, A ^a   Cox Froncillo, M C ^a   Aronica, G ^a   Bruno, A ^a   Del Moro, B ^a   Epiceno, A M ^a   Battaglia, A ^b   Forte, L ^a   Postorino, M ^a   Cordero, V ^a   Santinelli, S ^a   Amadori, S ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

AML; CD7; GP 170; Karyotype; Tdt

Indexed keywords

CD34 ANTIGEN; CD7 ANTIGEN; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REMISSION; TDT;

EID: 17344364483     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401067     Document Type: Article

References (14)

1. Terstappen LWMM, Safford M, Könemann S, Loken RL, Zurlutter K, Büchner T, Hiddemann W, Wörmann B. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1991; 5: 757-767.
2. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (FAB Cooperative Group). Proposals for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 1991; 78: 325-329.
3. Buccheri V, Matutes E, Dyer MJS, Catovsky D. Lineage commitment in biphenotypic acute leukemia. Leukemia 1993; 7: 919-927.
4. Greaves MF, Chan LC, Furley AJW, Watt SM, Molgaard HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986; 67: 1-11.
5. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S, Kyo T, Dohy H, Kamada N, Nasu K, Uchino H (The Japan Cooperative Group of Leukemia/Lymphoma). Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993; 81: 2399-2405.
6. Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Br J Haematol 1988; 68: 487-494.
7. Parreira A, Pombo de Oliveira MS, Matutes E, Foroni L, Morilla R, Catovsky D. Terminal deoxynucleotidyl transferase positive acute myeloid leukemia: an association with immature myeloblastic leukemia. Br J Haematol 1988; 69: 219-224.
8. Bradstock KF, Hoffbrand AV, Ganeshaguru K, Liewellin P, Patterson K, Wonke B, Prentice AC, Bennett M, Pizzolo G, Bollum FJ, Janossy G. Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukemia: an analysis by immunofluorescence. Br J Haematol 1981; 47: 133-143.
9. San Miguel JF, Gonzales M, Canizo MC, Anta JP, Portero JA, Lopez-Borrasca A. Tdt activity in acute myeloid leukemias defined by monoclonal antibodies. Am J Hematol 1986; 23: 9-17.
10. Lee EJ, Yang J, Leavitt RD, Testa JR, Civin CI, Forrest A, Schiffer CA. The significance of CD34 and Tdt determination in patients with untreated de novo acute myeloid leukemia. Leukemia 1992; 6: 1203-1209.
11. Drexler HG, Thiel E, Ludwig WD. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia 1993; 7: 489-498.
12. Vinante F, Pizzolo G, Rigo A, Vincenzi C, Sorio C, Cassatella M, Berton G. The CD4 molecule belongs to the phenotypic repertoire of most cases of acute myeloid leukemia. Leukemia 1992; 6: 1257-1262.
13. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 1994; 8: 388-394.
14. Venditti A, Del Poeta G, Stasi R, Masi M, Bruno A, Buccisano F, Cox C, Coppetelli U, Aronica G, Simone MD, Tribalto M, Amadori S, Papa G. Minimally differentiated acute myeloid leukaemia (AML-MO): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. Br J Haematol 1994; 88: 784-793.